LIQID Medical Developing the world's first definitive cure for severe glaucoma

LIQID Medical

LIQID Medical

LIQID Medical is a double award-winning biotechnology start-up company focused on developing truly innovative and high impact ophthalmic devices. Our flagship device, the OptiShunt, is a patented ocular implant which offers the first hope of a definitive cure for glaucoma, the leading cause of irreversible blindness worldwide. Our core mission is to prevent global blindness, particularly in Africa. Our vision is to establish ourselves as a valuable and leading biotechnology company.

Sectors Biotechnology and medical research
Location Cape Town, South Africa
Stage Sign in to view details
Markets Sign in to view details
Contact Sign in to view details
Social media